You are here

  • Home
  • Archive
  • Volume 12, Issue 9
  • Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study

Article info

Article menu
Oncology
Protocol
Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study

Authors

  • Ameeta Retzer Centre for Patient Reported Outcomes Research, Institute for Applied Health Research, University of Birmingham, Birmingham, UKNational Institute for Health and Care Research (NIHR) Applied Research Centre, West Midlands, Birmingham, UK PubMed articlesGoogle scholar articles
  • Stephanie Sivell Marie Curie Palliative Care Research Centre, Division of Population Medicine, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  • Hannah Scott Cambridge Public Health, University of Cambridge School of Clinical Medicine, University of Cambridge, Cambridge, UK PubMed articlesGoogle scholar articles
  • Annmarie Nelson Marie Curie Palliative Care Research Centre, Division of Population Medicine, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  • Helen Bulbeck brainstrust, Cowes, UK PubMed articlesGoogle scholar articles
  • Kathy Seddon Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  • Robin Grant Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh, UK PubMed articlesGoogle scholar articles
  • Richard Adams Centre for Trials Research, Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  • Colin Watts Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Olalekan Lee Aiyegbusi Centre for Patient Reported Outcomes Research, Institute for Applied Health Research, University of Birmingham, Birmingham, UKNIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Pamela Kearns Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UKNIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Samantha Cruz Rivera Centre for Patient Reported Outcomes Research, Institute for Applied Health Research, University of Birmingham, Birmingham, UKBirmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Linda Dirven Department of Neurology, Leiden University Medical Center, Leiden University, Leiden, The NetherlandsDepartment of Neurology, Medical Centre Haaglanden, Den Haag, The Netherlands PubMed articlesGoogle scholar articles
  • Elin Baddeley Marie Curie Palliative Care Research Centre, Division of Population Medicine, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  • Melanie Calvert Centre for Patient Reported Outcomes Research, Institute for Applied Health Research, University of Birmingham, Birmingham, UKNational Institute for Health and Care Research (NIHR) Applied Research Centre, West Midlands, Birmingham, UK PubMed articlesGoogle scholar articles
  • Anthony Byrne Marie Curie Palliative Care Research Centre, Division of Population Medicine, Cardiff University School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Anthony Byrne; Anthony.Byrne2{at}wales.nhs.uk
View Full Text

Citation

Retzer A, Sivell S, Scott H, et al
Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study
BMJ Open 2022;12:e057712. doi: 10.1136/bmjopen-2021-057712

Publication history

  • Received September 27, 2021
  • Accepted July 18, 2022
  • First published September 30, 2022.
Online issue publication 
March 28, 2024
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.